TY - JOUR
T1 - Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population
T2 - The Hisayama study
AU - on behalf of the
AU - Tsukuya, Go
AU - Matsumoto, Koichiro
AU - Fukuyama, Satoru
AU - Crawford, Bruce
AU - Nakanishi, Yoichi
AU - Ichinose, Masakazu
AU - Machida, Kentaro
AU - Samukawa, Takuya
AU - Ninomiya, Toshiharu
AU - Kiyohara, Yutaka
AU - Inoue, Hiromasa
N1 - Funding Information:
This study was supported in part by Nippon Boehringer Ingelheim and Pfizer Japan, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (HI, 25293192), and by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. The sponsors did not have direct influence on the study design or analysis.
Publisher Copyright:
© 2014 Japanese Society of Allergology
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Background Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. COPD is a treatable disease and it is important to identify COPD subjects, highlighting the need for an efficient screening measure. Although the COPD screening questionnaire (COPD Population Screener, COPD-PS) was developed as a screening tool, its validity is not clear in population-based studies. This study determines the validity of the COPD-PS in the general Japanese population. Methods All registered residents living in the town of Hisayama aged above 40 were solicited to participate in a health check-up in 2012. All subjects aged 40–79 without physician-diagnosed asthma or lung resection were recruited, and 2357 subjects with the COPD-PS recorded and valid spirometry measurements were analyzed. Persistent airflow obstruction (AO) was defined by post-bronchodilator FEV1/FVC < 0.7. The sensitivity and specificity of the COPD-PS score for identifying AO was assessed by logistic regression analysis. Results The prevalence of AO in this population was 6.5%. The overall area under the receiver operating characteristic (ROC) curve for the continuous COPD-PS score was 0.748. A cut-point of 4-points is recommended, resulting in a sensitivity of 67.1% and specificity of 72.9% with an area under the ROC curve of 0.70. The positive predictive value was 14.6% and negative predictive value was 97.0%. Conclusions The COPD-PS appears to be an adequate measure for large scale screening of possible airflow obstruction requiring further testing with spirometry.
AB - Background Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. COPD is a treatable disease and it is important to identify COPD subjects, highlighting the need for an efficient screening measure. Although the COPD screening questionnaire (COPD Population Screener, COPD-PS) was developed as a screening tool, its validity is not clear in population-based studies. This study determines the validity of the COPD-PS in the general Japanese population. Methods All registered residents living in the town of Hisayama aged above 40 were solicited to participate in a health check-up in 2012. All subjects aged 40–79 without physician-diagnosed asthma or lung resection were recruited, and 2357 subjects with the COPD-PS recorded and valid spirometry measurements were analyzed. Persistent airflow obstruction (AO) was defined by post-bronchodilator FEV1/FVC < 0.7. The sensitivity and specificity of the COPD-PS score for identifying AO was assessed by logistic regression analysis. Results The prevalence of AO in this population was 6.5%. The overall area under the receiver operating characteristic (ROC) curve for the continuous COPD-PS score was 0.748. A cut-point of 4-points is recommended, resulting in a sensitivity of 67.1% and specificity of 72.9% with an area under the ROC curve of 0.70. The positive predictive value was 14.6% and negative predictive value was 97.0%. Conclusions The COPD-PS appears to be an adequate measure for large scale screening of possible airflow obstruction requiring further testing with spirometry.
UR - http://www.scopus.com/inward/record.url?scp=84952329989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952329989&partnerID=8YFLogxK
U2 - 10.1016/j.alit.2014.06.002
DO - 10.1016/j.alit.2014.06.002
M3 - Article
C2 - 25572558
AN - SCOPUS:84952329989
SN - 1323-8930
VL - 64
SP - 49
EP - 53
JO - Allergology International
JF - Allergology International
IS - 1
ER -